Leveraging liquid biopsy to uncover resistance mechanisms and guide personalized immunotherapy
Cancer therapy has been revolutionized by immune checkpoint inhibitors (ICIs) that create a new paradigm among cancer immunotherapies. These agents restore the immune system capacity to fight cancer through blocking the action of major immune checkpoint proteins that suppress immune responses such a...
Saved in:
| Main Authors: | Zeinab Dalloul, Jana Grenel Briend, Mariama Diawara, Catherine Taylor, Rodney J. Ouellette |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001767 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinct microbial signatures of liquid biopsy samples during gastric carcinogenesis and insights from extracellular vesicle analysis
by: Hee Sang You, et al.
Published: (2025-07-01) -
Liquid biopsy – a narrative review with an update on current US governmental clinical trials targeting immunotherapy
by: Fan Shen, et al.
Published: (2025-12-01) -
Liquid biopsy based on EV biomarkers: A new frontier for early diagnosis and prognosis assessment of cancer at ESMO 2024
by: Zeping Shan, et al.
Published: (2025-12-01) -
Liquid biopsy: paving a new avenue for cancer research
by: Keerthi Kurma, et al.
Published: (2024-12-01) -
Nanotechnology-driven platforms for extracellular vesicle analysis in tumor immunotherapy
by: Rui Chen, et al.
Published: (2025-07-01)